 Arleta Rewers
Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetic Ketoacidosis | 39 | 2026 | 210 | 7.390 |
Why?
| | Diabetes Mellitus, Type 1 | 28 | 2026 | 3917 | 1.680 |
Why?
| | Fluid Therapy | 11 | 2023 | 154 | 1.350 |
Why?
| | Hypoglycemia | 7 | 2020 | 479 | 0.730 |
Why?
| | Diabetes Mellitus | 7 | 2023 | 1076 | 0.700 |
Why?
| | Acidosis | 1 | 2021 | 105 | 0.630 |
Why?
| | Child | 45 | 2026 | 22680 | 0.600 |
Why?
| | Insulin | 9 | 2026 | 2506 | 0.540 |
Why?
| | Adolescent | 35 | 2026 | 22485 | 0.490 |
Why?
| | Hyperglycemia | 4 | 2026 | 376 | 0.440 |
Why?
| | Hyperglycemic Hyperosmolar Nonketotic Coma | 3 | 2022 | 5 | 0.430 |
Why?
| | Child, Preschool | 22 | 2026 | 11837 | 0.400 |
Why?
| | Blood Glucose | 6 | 2023 | 2330 | 0.400 |
Why?
| | Inflammation Mediators | 2 | 2026 | 505 | 0.380 |
Why?
| | Colorado | 8 | 2024 | 4572 | 0.340 |
Why?
| | Infant | 17 | 2024 | 10064 | 0.320 |
Why?
| | Sodium | 2 | 2021 | 198 | 0.320 |
Why?
| | Hospitalization | 3 | 2016 | 2458 | 0.310 |
Why?
| | Hypoglycemic Agents | 5 | 2022 | 1392 | 0.300 |
Why?
| | Diabetic Nephropathies | 2 | 2022 | 318 | 0.270 |
Why?
| | Humans | 48 | 2026 | 145491 | 0.260 |
Why?
| | Quality Improvement | 1 | 2016 | 1294 | 0.260 |
Why?
| | 3-Hydroxybutyric Acid | 1 | 2006 | 17 | 0.250 |
Why?
| | Bicarbonates | 2 | 2017 | 45 | 0.240 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2017 | 563 | 0.230 |
Why?
| | Brain Injuries | 2 | 2022 | 507 | 0.220 |
Why?
| | Male | 29 | 2026 | 72817 | 0.220 |
Why?
| | Socioeconomic Factors | 4 | 2017 | 1327 | 0.210 |
Why?
| | Glasgow Coma Scale | 3 | 2021 | 218 | 0.210 |
Why?
| | Point-of-Care Systems | 1 | 2006 | 188 | 0.210 |
Why?
| | Severity of Illness Index | 8 | 2021 | 2945 | 0.210 |
Why?
| | Inflammation | 2 | 2026 | 2883 | 0.210 |
Why?
| | Female | 29 | 2026 | 78763 | 0.210 |
Why?
| | Femoral Fractures | 1 | 2005 | 84 | 0.210 |
Why?
| | Biomarkers | 4 | 2026 | 4283 | 0.200 |
Why?
| | Prevalence | 5 | 2024 | 2855 | 0.200 |
Why?
| | Multiple Trauma | 1 | 2005 | 121 | 0.200 |
Why?
| | Emergency Service, Hospital | 5 | 2023 | 2379 | 0.200 |
Why?
| | Acute Kidney Injury | 2 | 2021 | 873 | 0.190 |
Why?
| | Hypertension | 2 | 2023 | 1273 | 0.190 |
Why?
| | Electrolytes | 2 | 2021 | 54 | 0.190 |
Why?
| | Cytokines | 2 | 2026 | 2054 | 0.170 |
Why?
| | Matrix Metalloproteinases | 2 | 2026 | 95 | 0.170 |
Why?
| | White Matter | 1 | 2023 | 153 | 0.170 |
Why?
| | Neurocognitive Disorders | 1 | 2020 | 33 | 0.160 |
Why?
| | Kidney Tubules | 1 | 2021 | 118 | 0.160 |
Why?
| | Communicable Disease Control | 1 | 2021 | 86 | 0.160 |
Why?
| | Brain Edema | 3 | 2018 | 62 | 0.160 |
Why?
| | Risk Factors | 9 | 2022 | 10874 | 0.160 |
Why?
| | Emergencies | 1 | 2020 | 175 | 0.140 |
Why?
| | Rehydration Solutions | 1 | 2018 | 9 | 0.140 |
Why?
| | Incidence | 4 | 2015 | 2915 | 0.140 |
Why?
| | Logistic Models | 3 | 2015 | 2130 | 0.130 |
Why?
| | Endocrinology | 1 | 2018 | 77 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 470 | 0.120 |
Why?
| | Pediatrics | 3 | 2018 | 1121 | 0.120 |
Why?
| | Pediatric Obesity | 1 | 2023 | 637 | 0.120 |
Why?
| | Pandemics | 2 | 2022 | 1706 | 0.120 |
Why?
| | Cognition | 2 | 2023 | 1268 | 0.110 |
Why?
| | Prognosis | 4 | 2026 | 4323 | 0.110 |
Why?
| | Length of Stay | 2 | 2016 | 1348 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2016 | 195 | 0.110 |
Why?
| | Treatment Outcome | 3 | 2016 | 11831 | 0.110 |
Why?
| | Prospective Studies | 5 | 2021 | 8039 | 0.100 |
Why?
| | Cohort Studies | 5 | 2023 | 5992 | 0.100 |
Why?
| | Blood Pressure | 1 | 2020 | 1782 | 0.100 |
Why?
| | Infant, Newborn | 4 | 2019 | 6437 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2016 | 557 | 0.090 |
Why?
| | Adolescent Development | 1 | 2013 | 72 | 0.090 |
Why?
| | Insulin Infusion Systems | 1 | 2017 | 478 | 0.090 |
Why?
| | United States | 5 | 2020 | 16115 | 0.090 |
Why?
| | Follow-Up Studies | 2 | 2018 | 5426 | 0.080 |
Why?
| | Combined Modality Therapy | 2 | 2014 | 1269 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 738 | 0.080 |
Why?
| | Blood Urea Nitrogen | 3 | 2022 | 53 | 0.080 |
Why?
| | Infusions, Intravenous | 2 | 2023 | 427 | 0.080 |
Why?
| | Precision Medicine | 1 | 2014 | 456 | 0.080 |
Why?
| | Emergency Medical Services | 2 | 2018 | 697 | 0.080 |
Why?
| | Triage | 1 | 2012 | 252 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2950 | 0.070 |
Why?
| | Patient Transfer | 1 | 2012 | 211 | 0.070 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2014 | 2582 | 0.070 |
Why?
| | Blood Chemical Analysis | 1 | 2010 | 110 | 0.070 |
Why?
| | Sodium Chloride | 2 | 2021 | 143 | 0.070 |
Why?
| | Amylases | 1 | 2008 | 18 | 0.070 |
Why?
| | Consensus | 2 | 2022 | 483 | 0.070 |
Why?
| | Glomerular Filtration Rate | 2 | 2023 | 765 | 0.070 |
Why?
| | Practice Guidelines as Topic | 1 | 2016 | 1585 | 0.070 |
Why?
| | Child Development | 1 | 2013 | 484 | 0.070 |
Why?
| | Lipase | 1 | 2008 | 75 | 0.070 |
Why?
| | Monitoring, Physiologic | 1 | 2010 | 288 | 0.070 |
Why?
| | Dehydration | 2 | 2023 | 59 | 0.060 |
Why?
| | Electrochemistry | 1 | 2006 | 72 | 0.060 |
Why?
| | Drug Administration Schedule | 2 | 2018 | 782 | 0.060 |
Why?
| | Educational Status | 1 | 2008 | 465 | 0.060 |
Why?
| | Retrospective Studies | 4 | 2023 | 17269 | 0.060 |
Why?
| | Small-Area Analysis | 1 | 2005 | 6 | 0.060 |
Why?
| | Abbreviated Injury Scale | 1 | 2005 | 28 | 0.060 |
Why?
| | Insurance, Health | 1 | 2008 | 308 | 0.060 |
Why?
| | Models, Biological | 1 | 2012 | 1815 | 0.050 |
Why?
| | Survival Rate | 1 | 2010 | 2093 | 0.050 |
Why?
| | Medically Uninsured | 1 | 2005 | 132 | 0.050 |
Why?
| | Diagnosis, Differential | 3 | 2018 | 1507 | 0.050 |
Why?
| | International Classification of Diseases | 1 | 2005 | 148 | 0.050 |
Why?
| | Wounds and Injuries | 1 | 2012 | 964 | 0.050 |
Why?
| | Multivariate Analysis | 2 | 2008 | 1544 | 0.050 |
Why?
| | Aspartic Acid | 1 | 2023 | 87 | 0.050 |
Why?
| | Creatine | 1 | 2023 | 63 | 0.050 |
Why?
| | Threonine | 1 | 2022 | 44 | 0.050 |
Why?
| | Histidine | 1 | 2022 | 65 | 0.040 |
Why?
| | Choline | 1 | 2023 | 137 | 0.040 |
Why?
| | Emergency Medicine | 1 | 2005 | 282 | 0.040 |
Why?
| | Heart Diseases | 1 | 2005 | 342 | 0.040 |
Why?
| | Multicenter Studies as Topic | 1 | 2023 | 411 | 0.040 |
Why?
| | Electrocardiography | 1 | 2005 | 669 | 0.040 |
Why?
| | Leucine | 1 | 2022 | 116 | 0.040 |
Why?
| | Glycopeptides | 1 | 2021 | 44 | 0.040 |
Why?
| | Intelligence Tests | 1 | 2020 | 55 | 0.040 |
Why?
| | Tryptophan | 1 | 2022 | 175 | 0.040 |
Why?
| | Mental Status and Dementia Tests | 1 | 2020 | 26 | 0.040 |
Why?
| | Chlorides | 1 | 2021 | 142 | 0.040 |
Why?
| | Uric Acid | 1 | 2021 | 167 | 0.040 |
Why?
| | Creatinine | 1 | 2022 | 513 | 0.040 |
Why?
| | Risk Assessment | 1 | 2010 | 3759 | 0.040 |
Why?
| | Registries | 2 | 2022 | 2410 | 0.040 |
Why?
| | Parents | 1 | 2008 | 1404 | 0.040 |
Why?
| | Acute Disease | 1 | 2002 | 1040 | 0.040 |
Why?
| | Overweight | 1 | 2023 | 607 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2023 | 1058 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3897 | 0.030 |
Why?
| | Amino Acids | 1 | 2022 | 521 | 0.030 |
Why?
| | Memory | 1 | 2020 | 297 | 0.030 |
Why?
| | International Cooperation | 1 | 2018 | 197 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1039 | 0.030 |
Why?
| | Pilot Projects | 1 | 2023 | 1896 | 0.030 |
Why?
| | Patient Care Planning | 1 | 2018 | 170 | 0.030 |
Why?
| | Clinical Competence | 1 | 2005 | 1242 | 0.030 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2023 | 1755 | 0.030 |
Why?
| | Sex Factors | 1 | 2002 | 2110 | 0.030 |
Why?
| | Self Efficacy | 1 | 2018 | 409 | 0.030 |
Why?
| | International Agencies | 1 | 2014 | 30 | 0.030 |
Why?
| | Age Factors | 1 | 2002 | 3340 | 0.030 |
Why?
| | Adolescent Medicine | 1 | 2014 | 26 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2014 | 50 | 0.030 |
Why?
| | Societies, Medical | 1 | 2018 | 898 | 0.030 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2018 | 699 | 0.020 |
Why?
| | Mental Disorders | 1 | 2002 | 1157 | 0.020 |
Why?
| | Child Mortality | 1 | 2012 | 16 | 0.020 |
Why?
| | Syndrome | 1 | 2012 | 380 | 0.020 |
Why?
| | Adult | 3 | 2013 | 40707 | 0.020 |
Why?
| | Brain | 1 | 2023 | 2944 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2014 | 400 | 0.020 |
Why?
| | Risk | 1 | 2013 | 917 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2012 | 602 | 0.020 |
Why?
| | Exercise | 2 | 2014 | 2192 | 0.020 |
Why?
| | Circadian Rhythm | 1 | 2014 | 512 | 0.020 |
Why?
| | Speech Disorders | 1 | 2009 | 29 | 0.020 |
Why?
| | Trauma Centers | 1 | 2012 | 468 | 0.020 |
Why?
| | Practice Patterns, Physicians' | 1 | 2018 | 1369 | 0.020 |
Why?
| | Glucagon | 1 | 2009 | 114 | 0.020 |
Why?
| | Hyperventilation | 1 | 2008 | 15 | 0.020 |
Why?
| | Mood Disorders | 1 | 2009 | 140 | 0.020 |
Why?
| | Osmolar Concentration | 1 | 2008 | 169 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2016 | 3619 | 0.020 |
Why?
| | Magnesium | 1 | 2008 | 156 | 0.020 |
Why?
| | Hospitals, University | 1 | 2008 | 176 | 0.020 |
Why?
| | Vision Disorders | 1 | 2009 | 179 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7171 | 0.020 |
Why?
| | Respiration | 1 | 2008 | 206 | 0.020 |
Why?
| | Phosphates | 1 | 2008 | 177 | 0.020 |
Why?
| | Awareness | 1 | 2008 | 111 | 0.020 |
Why?
| | Eating | 1 | 2009 | 388 | 0.020 |
Why?
| | Young Adult | 2 | 2014 | 14192 | 0.020 |
Why?
| | Age of Onset | 1 | 2008 | 554 | 0.010 |
Why?
| | Cerebral Ventricles | 1 | 2006 | 55 | 0.010 |
Why?
| | Triglycerides | 1 | 2008 | 518 | 0.010 |
Why?
| | Parent-Child Relations | 1 | 2008 | 271 | 0.010 |
Why?
| | Headache | 1 | 2006 | 151 | 0.010 |
Why?
| | Cardiology | 1 | 2005 | 365 | 0.010 |
Why?
| | Medicaid | 1 | 2005 | 466 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 2002 | 0.010 |
Why?
|
|
Rewers's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|